Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00463554 · ClinicalTrials.gov registry record
TVT-SECUR A Pilot Study for the Treatment of Stress Urinary Incontinence
A clinical trial, sponsored by Ethicon.
- Completed
- Registry status
- 72
- Enrollment target
NCT00463554: Completed study, sponsored by Ethicon.
NCT00463554 is a clinical trial that has completed, run by Ethicon. The registered enrollment target is 72 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00463554 has completed, sponsored by Ethicon.
- COMPLETED
- Registry status
- 72 participants
- Enrollment target
Study Summary
The primary objective of this study is to obtain clinical performance information on the GYNECARE TVT-SECUR\* System (Tension-free Support for Incontinence) in women with stress urinary incontinence (SUI).
Interventions
- DEVICE GYNECARE TVT-SECUR* System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2006-04-01 |
| Est. Completion | 2007-12-01 |
What the finished NCT00463554 record still lists
NCT00463554 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 72 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which GYNECARE TVT-SECUR* System is the first listed.
NCT00463554 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00463554 about?
NCT00463554 is a clinical study titled "TVT-SECUR A Pilot Study for the Treatment of Stress Urinary Incontinence". The primary objective of this study is to obtain clinical performance information on the GYNECARE TVT-SECUR\* System (Tension-free Support for Incontinence) in women with stress urinary incontinence (SUI).
What is the current status of trial NCT00463554?
This trial is currently completed. The enrollment target is 72 participants. The study started on 2006-04-01. Estimated completion is 2007-12-01.
What interventions are being tested in trial NCT00463554?
The interventions under investigation include: GYNECARE TVT-SECUR* System (DEVICE).
Who is sponsoring clinical trial NCT00463554?
This trial is sponsored by Ethicon, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02359253 · 72 participants · NA
Robot Aided Rehabilitation - Intervention
- NCT02962661 · 72 participants · Phase 1
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- NCT03113643 · 72 participants · Phase 1
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- NCT03187535 · 72 participants · NA
Effect of TEAS on PONV After Spinal Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI